New Delhi [India], April 13 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
Hyderabad (Telangana) [India], April 9 (ANI): Welcoming the decision to make precautionary dose available for all adults, Hyderabad-based vaccine manufacturer Bharat Biotech on Saturday, announced that it has revised the price of its COVID vaccine Covaxin from Rs 1,200 to Rs 225 per dose for
New Delhi [India], April 8 (ANI): World Health Organization (WHO) suspending the supply of Covaxin through UN procurement agencies over "process and facility upgrade" requirements will not have an impact on travel by those who have taken the COVID vaccine, Ministry of External Affairs said o
Tokyo [Japan], April 7 (ANI): Japan recognizes India's COVID-19 vaccine COVAXIN manufactured by Bharat Biotech with effect from April 10 to further facilitate travel from India to Japan, said the Indian Embassy in Japan on Thursday.
New Delhi [India], April 4 (ANI): Hyderabad-based pharmaceutical company, Bharat Biotech will rectify the issues raised by the World Health Organization regarding its COVID-19 vaccine-- Covaxin-- in a few days and added that the company has informed about this development to the Drugs Con
New Delhi [India], April 4 (ANI): The World Health Organization's (WHO) suspension of supplies of Covaxin of the Bharat Biotech supply is not related to safety or efficacy issues but only to supply for United Nations agencies, sources said.
Hyderabad (Telangana)[India], April 3 (ANI): Hyderabad-based Bharat Biotech on Sunday issued a clarification that there is "no impact on efficacy and safety of the COVID-19 vaccine COVAXIN" after the World Health Organisation suspended it from its Covax facility.
Hyderabad (Telangana) [India], April 1 (ANI): Bharat Biotech on Friday announced the temporary slowing down of production of COVAXIN across its manufacturing facilities, having completed its supply obligations to procurement agencies and foreseeing the decrease in demand.
New Delhi [India], March 28 (ANI): Bharat Biotech Managing Director (MD) D Krishna Ella and Joint MD Suchitra Ella received the Padma Bhushan award from President Ram Nath Kovind on Monday.
New Delhi [India], March 7 (ANI): Bharat Biotech's COVID-19 vaccine Covaxin has been given clearance for clinical trials in adults by the US Food and Drug Administration (FDA).
Washington [US], February 24 (ANI): Microsoft co-founder Bill Gates, at a virtual event of the India-US Health Partnership roundtable on "Vaccine for All", on Tuesday, said that India's 3 vaccines -- Covaxin, Corbavex and Covishield -- were the products of partnerships that bridged sectors a
Hyderabad (Telangana) [India], February 19 (ANI): Hyderabad-based Bharat Biotech on Saturday said its COVID-19 vaccine Covaxin will be evaluated as a vaccine candidate for the disease in the United States.